肝癌术后早期复发转移的预测

外科研究与新技术 ›› 2013, Vol. 2 ›› Issue (4): 259-261.

肝癌术后早期复发转移的预测

黎蕴通，罗顺峰(综述)，刘景丰(审校)

福建医科大学孟超肝胆医院，福州 350000

出版日期:2013-12-28 发布日期:2013-04-25
通讯作者: 刘景丰,E-mail:drjingfeng@126.com
作者简介:黎蕴通(1986-),男,博士研究生,主要研究方向为肝胆外科。

Advances in research on prediction for early postoperative metastasis and recurrence in patients with hepatocellular carcinoma

LI Yun-tong, LUO Shun-feng, LIU Jing-feng

Mengchao Hepatobiliary Hospital,Fujian Medical University,Fuzhou 350000,China

Online:2013-12-28 Published:2013-04-25

摘要/Abstract

摘要： 肿瘤术后复发转移是影响癌症病人预后的重要因素。尽早发现肝癌术后复发和转移对提高肝癌病人疗效有重要意义。本文就肝癌术后早期复发转移预测的进展包括肝癌术后复发时间与预后，肝癌早期复发转移分子预测及其数学模型作一综述。

关键词: 肝癌, 复发, 转移, 预测

Abstract: Recurrence and metastasis of the tumor is an important prognostic factor in patients with cancer. Early detection of postoperative recurrence and metastasis in patients with hepaocellular carcinoma (HCC) has an important significance for improvement of prognosis of HCC patients. This article reviews advances in research on prediction for early postoperative recurrence and metastasis of HCCs including recurrence time and prognosis after hepatectomy for HCC, molecular prediction for early recurrence and metastasis of HCC and its mathematical model.

Key words: Hepatocellular carcinoma, Recurrence, Metastasis, Prediction

中图分类号:

R735.7

黎蕴通，罗顺峰(综述)，刘景丰(审校). 肝癌术后早期复发转移的预测[J]. 外科研究与新技术, 2013, 2(4): 259-261.

LI Yun-tong, LUO Shun-feng, LIU Jing-feng. Advances in research on prediction for early postoperative metastasis and recurrence in patients with hepatocellular carcinoma[J]. Surgical Research and New Technique, 2013, 2(4): 259-261.

参考文献

[1]Ikai I,Arii S,Okazaki M,et al.Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan[J].Hepatol Res,2007,37(9):676-91.
[2] Poon RT,Fan ST,Lo CM,et al.Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years[J].Ann Surg,2001,234(1):63-70.
[3] Hanazaki K,Kajikawa S,Shimozawa N,et al.Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma[J].J Am Coll Surg,2000,191(4):381-388.
[4] Shimada M,Hasegawa H,Gion T,et al.Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy[J].Hepatogastroenterology,1999,46(28):2469-2475.
[5] Chan AC,Poon RT,Cheung TT,et al.Survival analysis of re-resection versus adiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma[J].World J Surg,2012,36(1):151-156.
[6] Ho CM,Lee PH,Shau WY,et al.Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities[J].Surgery,2012,151(5):700-709.
[7] Ye QH,Qin LX,Forgues M,et al.Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning[J].Nat Med,2003,9(4):416-423.
[8] Lizuka N,Oka M,Nishida M,et al.Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection[J].Lancet,2003,361(9361):923-929.
[9] 黄尧,池闽辉,曾永毅,等.肝细胞癌根治术后早期肺转移影响因素分析及预测的数学模型[J].中华实验外科杂志,2012,29(7):1383-1385.
[10] Huang X,Wei W,Ya N,et al.A mathematical model to predict short-term recurrence and metastasis of primary hepatocellular carcinoma larger than 10 cm in diameter[J].Hepatogastroenterology,2013,60(122):225-230.

[1]	严国鑫, 任航. 低温等离子射频术与高频电刀在早期舌癌治疗中的临床比较[J]. 外科研究与新技术, 2021, 10(1): 42-44.
[2]	王晖, 王芳涛, 范跃祖. 抗淋巴管生成治疗结直肠癌研究进展[J]. 外科研究与新技术, 2021, 10(1): 64-67.
[3]	金海龙, 武彪, 张毅. 乳腺癌术后患者不同局部区域复发对预后的影响[J]. 外科研究与新技术, 2020, 9(3): 149-153.
[4]	林其炎, 何咏超, 张晓峰. 开颅血肿清除和钻孔引流对硬膜下血肿患者疗效及预后研究[J]. 外科研究与新技术, 2020, 9(2): 94-96.
[5]	刘丛丛, 施宝民. 肝癌经皮射频消融治疗后完全消融率的影响因素研究[J]. 外科研究与新技术, 2020, 9(1): 1-5.
[6]	吴松龄, 张美泽, 刘佳慧, 詹巧惠. 98例早期乳腺癌非前哨淋巴结转移的影响因素分析[J]. 外科研究与新技术, 2020, 9(1): 6-9.
[7]	桑鸿雁, 张敏. 腹腔镜疝修补术治疗腹股沟疝的效果分析[J]. 外科研究与新技术, 2019, 8(4): 234-236.
[8]	曾丽红. 应用活动性疼痛评估的针对性护理对肝癌术后患者疼痛、睡眠及术后恢复的影响[J]. 外科研究与新技术, 2019, 8(4): 288-290.
[9]	翁海兵, 沈银奎, 钱声华. 前列腺突入膀胱程度对前列腺增生患者前列腺等离子电切术后效果的预测评估作用[J]. 外科研究与新技术, 2019, 8(3): 183-186.
[10]	刘鹏飞, 徐雯, 刘凯, 叶春. 肝癌术后输血后溶血所致高胆红素血症2例报告[J]. 外科研究与新技术, 2019, 8(1): 58-59.
[11]	刘鹏飞, 刘凯, 叶春, 徐雯. 原发性肝癌术中大出血的原因及外科处理[J]. 外科研究与新技术, 2017, 6(3): 152-154.
[12]	张涛施宝民王洪崔乃鹏林锐季堃. 乳腺癌前哨淋巴结阳性时非前哨淋巴结转移的相关因素分析[J]. 外科研究与新技术, 2017, 6(1): 1-4.
[13]	丁苇. 小肝癌TACE联合射频消融序贯治疗与手术切除的疗效对比[J]. 外科研究与新技术, 2016, 5(4): 237-240.
[14]	赵晨周悦骆金华张杨杨张辉. 早期食管癌淋巴结转移风险的相关因素分析[J]. 外科研究与新技术, 2016, 5(3): 145-149.
[15]	张文忠凌杰徐斌邱伟王永兵. 血管生成拟态与大肠癌肝转移相关性探究[J]. 外科研究与新技术, 2016, 5(3): 162-164,172.